131 related articles for article (PubMed ID: 31608454)
1. Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization.
Nelson KA; Aldea GS; Warner P; Latchman Y; Gunasekera D; Tamir A; Gernsheimer T; Bolgiano D; Slichter SJ
Transfusion; 2019 Nov; 59(11):3396-3404. PubMed ID: 31608454
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH
Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103
[TBL] [Abstract][Full Text] [Related]
3. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.
Yu J; Heck S; Yazdanbakhsh K
Am J Hematol; 2007 Aug; 82(8):691-6. PubMed ID: 17492644
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model.
Slichter SJ; Fish D; Abrams VK; Gaur L; Nelson K; Bolgiano D
Blood; 2005 Jan; 105(2):847-54. PubMed ID: 15231575
[TBL] [Abstract][Full Text] [Related]
5. Irradiation of Red Blood Cells and Alloimmunization.
Tormey CA; Hendrickson JE
Lab Med; 2017 May; 48(2):172-177. PubMed ID: 28340248
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloantibodies are associated with increased alloimmunization against human leukocyte antigens.
Belizaire R; Mack J; Kadauke S; Kim Y; Saidman S; Makar RS
Transfusion; 2019 Jul; 59(7):2256-2263. PubMed ID: 30980544
[TBL] [Abstract][Full Text] [Related]
7. CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.
Gilson CR; Patel SR; Zimring JC
Transfusion; 2012 Oct; 52(10):2209-19. PubMed ID: 22321003
[TBL] [Abstract][Full Text] [Related]
8. Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products.
Coppage M; Baker M; Fialkow L; Meehan D; Gettings K; Chen L; Massey HT; Blumberg N
Hum Immunol; 2009 Jun; 70(6):413-6. PubMed ID: 19275923
[TBL] [Abstract][Full Text] [Related]
9. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Muench MO; Heitman JW; Inglis H; Fomin ME; Marschner S; Goodrich RP; Norris PJ; Jackman RP
Transfusion; 2016 Jun; 56(6):1419-29. PubMed ID: 27028210
[TBL] [Abstract][Full Text] [Related]
10. Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.
Bynum JP; Zachary A; Ness PM; Luo X; Bagnasco S; King KE; Segev DL; Orandi BJ; Warren DS; Fuller A; Ciappi A; Montgomery R; Tobian AAR
Transfusion; 2018 Aug; 58(8):1951-1957. PubMed ID: 30171817
[TBL] [Abstract][Full Text] [Related]
11. HLA alloimmunization of surgical patients by transfusion with bedside leukoreduced blood components.
Ohto H; Nomizu T; Kuroda F; Hoshi T; Rokkaku Y
Fukushima J Med Sci; 2003 Jun; 49(1):45-54. PubMed ID: 14603951
[TBL] [Abstract][Full Text] [Related]
12. Stored red blood cell transfusion induces regulatory T cells.
Baumgartner JM; Silliman CC; Moore EE; Banerjee A; McCarter MD
J Am Coll Surg; 2009 Jan; 208(1):110-9. PubMed ID: 19228512
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.
Drakos SG; Stringham JC; Long JW; Gilbert EM; Fuller TC; Campbell BK; Horne BD; Hagan ME; Nelson KE; Lindblom JM; Meldrum PA; Carlson JF; Moore SA; Kfoury AG; Renlund DG
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1612-9. PubMed ID: 17532964
[TBL] [Abstract][Full Text] [Related]
14. The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs.
Richards AL; Sheldon K; Wu X; Gruber DR; Hudson KE
Front Immunol; 2018; 9():2200. PubMed ID: 30344520
[No Abstract] [Full Text] [Related]
15. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet B irradiation in the prevention of alloimmunization in a dog platelet transfusion model.
Slichter SJ; Abrams K; Gettinger I; Christoffel T; Gaur L; Latchman Y; Nelson K; Pellham E; Bailey SL; Bolgiano D
Transfusion; 2016 Jun; 56(6):1340-7. PubMed ID: 27184061
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the alloimmune response by blood transfusions.
Claas FH; Roelen DL; van Rood JJ; Brand A
Transfus Clin Biol; 2001 Jun; 8(3):315-7. PubMed ID: 11499985
[TBL] [Abstract][Full Text] [Related]
19. Anti-class II antibody production prolongs renal allograft survival.
Lewis RE; Brackin MN; Cruse JM; Brackin BT; Butkus D; Raju S; Crawford M; Krueger R; Kirchner K; Bower J
Pathol Immunopathol Res; 1989; 8(5-6):287-99. PubMed ID: 2633201
[TBL] [Abstract][Full Text] [Related]
20. Induction of a secondary human anti-HLA alloimmune response in severe combined immunodeficient mice engrafted with human lymphocytes.
Lazarus AH; Crow AR; Semple JW; Cosgrave D; Kalovsky EJ; Hannach B; Blanchette V; Freedman J
Transfusion; 1997; 37(11-12):1192-9. PubMed ID: 9426645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
